VC  Catalio Capital

     Office Locations:

New York, NY



  • Early
  • Seed



  • Life Sciences & Healthcare
  • Medical Device



    Catalio was founded in 2020 by George Petrocheilos and R. Jacob Vogelstein to invest in the next generation of category-defining life sciences companies around the globe. The mission is to produce extraordinary returns by creating and sustaining life sciences companies that combine the best science and technology with the best management teams and financial syndicates. To achieve this objective, they work with the world's best scientists, engineers and clinicians to identify breakthrough biotechnologies; co-invest with top-tier funds; and recruit A-list talent from our collective networks. The firm focuses on biomedical technology companies developing next-generation drugs, devices and diagnostics.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    George C. Petrocheilos Managing Partner
    George C. Petrocheilos Managing Partner
    Holly Barra Analyst
    John Henry Iucker Partner
    R. Jacob Vogelstein Managing Partner


    Recent Funding Events (trailing 12 months):










      Series A


    Portfolio companies include:



    Recent News: